Scleroderma Mesenchymal Stem Cells display a different phenotype from healthy controls; implications for regenerative medicine-Reference-Cited by-同舟云学术

Scleroderma Mesenchymal Stem Cells display a different phenotype from healthy controls; implications for regenerative medicine

Published:2013-02-15 Issue:3 Volume:16 Page:595-607
ISSN:0969-6970
Container-title:Angiogenesis
language:en
Short-container-title:Angiogenesis

Author:

Cipriani Paola,Marrelli Alessandra,Benedetto Paola Di,Liakouli Vasiliki,Carubbi Francesco,Ruscitti Piero,Alvaro Saverio,Pantano Ilenia,Campese Antonio Francesco,Grazioli Paola,Screpanti Isabella,Giacomelli Roberto

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Clinical Biochemistry,Physiology

Link

http://link.springer.com/content/pdf/10.1007/s10456-013-9338-9.pdf

Reference52 articles.

1. LeRoy EC (1996) Systemic sclerosis. A vascular perspective. Rheum Dis Clin North Am 22:675–694

2. Kahaleh MB (2004) Vascular involvement in systemic sclerosis (SSc). Clin Exp Rheumatol 22(3 Suppl 33): S19–S23

3. Fleming JN, Nash RA, Mahoney WM Jr, Schwartz SM (2009) Is scleroderma a vasculopathy? Curr Rheumatol Rep 11:103–110

4. Cipriani P, Guiducci S, Miniati I, Cinelli M, Urbani S et al (2007) Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells:new insight into the pathogenesis of systemic sclerosis. Arthritis Rheum 56:1994–2004

5. Manetti M, Ibba-Manneschi L, Liakouli V, Guiducci S, Milia AF et al (2010) The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis. Ann Rheum Dis 69:598–605

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mesenchymal stem cells in autoimmune disease: A systematic review and meta-analysis of pre-clinical studies;Biochimie;2024-08

2. TGF-β1 Drives Integrin-Dependent Pericyte Migration and Microvascular Destabilization in Fibrotic Disease;The American Journal of Pathology;2024-07

3. Mesenchymal stem cell-based therapy for autoimmune-related fibrotic skin diseases—systemic sclerosis and sclerodermatous graft-versus-host disease;Stem Cell Research & Therapy;2023-12-18

4. Local administration of mesenchymal stromal cells is safe and modulates the immune compartment in ulcerative proctitis;JCI Insight;2023-05-08

5. Mesenchymal Stem Cell–Based Therapy as a New Approach for the Treatment of Systemic Sclerosis;Clinical Reviews in Allergy & Immunology;2022-01-15